Quantcast

Latest Dabigatran Stories

2014-06-13 23:07:06

As Flood Law Group continues to investigate Pradaxa lawsuits, the company Boehringer Ingelheim has just paid $650 million to settle thousands of lawsuits against the drug company, according to a May 28, 2014 NY Times article. Washington, D.C. (PRWEB) June 13, 2014 Flood Law Group is pleased with the outcome of the settlement of thousands of lawsuits against the drug manufacturer Boehringer Ingelheim for alleged injuries due to the drug Pradaxa, according to a May 28, 2014 NY Times...

2014-06-10 23:13:15

The Long Island, New York law firm of Rudolph F. X. Migliore, P. C. has announced the makers of the drug called Pradaxa have agreed to pay out 650 million to resolve most of the 4,000 cases filed in state and federal courts. (PRWEB) June 10, 2014 The New York Times states, “Pradaxa, which was approved in 2010, was the first in a new group of blood thinners intended to replace an older treatment, warfarin, which required patients to submit to frequent blood tests and adhere to a strict...

2014-06-10 12:29:47

Additional Novel Oral Anticoagulants are Expected to Gain Approval in China for AF and VTE in the Next Three to Four Years, According to Findings from Decision Resources Group BURLINGTON, Mass., June 10, 2014 /PRNewswire/ -- Decision Resources Group finds that the high cost of therapy remains a significant barrier for uptake of novel oral anticoagulants (NOACs) in the Chinese market. Warfarin, the mainstay of anticoagulation treatment, is listed in the national essential drugs list and is...

2014-06-05 23:01:35

A recent settlement announcement involving Pradaxa has been announced by the manufacture, Boehringer Ingelheim. Toledo, Ohio (PRWEB) June 05, 2014 Boehringer Ingelheim, the manufacturing company of the blood thinning drug Pradaxa, announced in May 2014 a $650 million settlement deal this week to settle approximately 4,000 state and federal lawsuits. Reported by TIME May 2014, Pradaxa was approved by the US Food and Drug Administration (FDA) in October 2010, Pradaxa is formulated for use...

2014-06-03 23:14:55

German pharmaceutical company Boehringer Ingelheim GmbH has agreed to settle thousands of claims against the drug manufacturer for injuries and deaths caused by the blood thinner Pradaxa. Columbus, Ohio (PRWEB) June 03, 2014 O’Connor, Acciani & Levy, an Ohio pharmaceutical litigation firm, continue to investigate claims regarding Pradaxa, a blood thinner manufactured by German pharmaceutical company Boehringer Ingelheim GmbH. According to a Bloomberg report published on May 28,...

2014-05-31 23:04:13

Greg Coleman Law reviews the impact of Boehringer’s settlement offer and the drugmaker’s motivations in light of the more than 4,000 pending Pradaxa lawsuits in U.S. courts. Knoxville, TN (PRWEB) May 31, 2014 Greg Coleman Law, a Tennessee defective drug litigation law firm, continues to express concerns about the proposed Pradaxa litigation settlement announced by Boehringer Ingelheim GmbH on May 28, 2014. The firm continues to review and investigate claims that the blood thinner...

2014-05-29 23:15:58

Boehringer Ingelheim Agrees to Pay $650 Million To Settle 4,000 Pradaxa Lawsuit That Allege Internal Bleeding After Taking The Prescription Medication. Columbus, OH (PRWEB) May 29, 2014 Wright & Schulte LLC, an experienced personal injury law firm representing plaintiffs in Pradaxa lawsuits pending in federal court, reports that Boehringer Ingelheim has agreed to pay $650 million to settle Pradaxa lawsuits filed on behalf of plaintiffs who allegedly experienced serious internal...

2014-05-28 23:02:26

The Firm is evaluating Pradaxa bleeding claims on behalf of individuals who allegedly suffered life-threatening episodes of internal hemorrhaging due to their use of Pradaxa. New York, New York (PRWEB) May 28, 2014 As Pradaxa lawsuits (http://www.pradaxalawsuithelp.com/) continue to mount in federal court, Bernstein Liebhard LLP notes that the manufacturer of the blood thinner has acknowledged that a number of serious bleeding events were omitted from the original report on a clinical...

2014-05-28 23:01:48

Seth A. Katz and Burg Simpson Eldredge Hersh & Jardine, P.C. are pleased to announce that earlier today Boehringer Ingelheim Pharmaceuticals, Inc. and its related companies agreed to pay $650,000,000 to settle close to 4,000 claims brought on behalf of individuals who were injured after taking the company’s anticoagulant drug, Pradaxa (dabigatran etexilate). (PRWEB) May 28, 2014 Denver, Colorado: Seth A. Katz and Burg Simpson Eldredge Hersh & Jardine, P.C. are pleased to...

2014-05-28 08:31:29

RIDGEFIELD, Conn., May 28, 2014 /PRNewswire/ -- Boehringer Ingelheim (BI) announced today that it has reached a comprehensive settlement of state and federal cases in the U.S. litigation regarding Pradaxa® (dabigatran etexilate mesylate) in the amount of $650 million. "Time and again, the benefits and safety of PRADAXA have been confirmed," said Desiree Ralls-Morrison, senior vice president and general counsel, Boehringer Ingelheim USA Corporation. "BI stands resolutely behind PRADAXA and...


Word of the Day
bodacious
  • Remarkable; prodigious.
  • Audacious; gutsy.
  • Completely; extremely.
  • Audaciously; boldly.
  • Impressively great in size; enormous; extraordinary.
This word is probably from the dialectal 'boldacious,' a blend of 'bold' and 'audacious.'
Related